AMRN

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Amarin Corporation PLC

NASDAQ | AMRN

19.32

USD

+$0.00

(

+0.00%

)

At Close (As of Oct 14, 2025)

$396.49M

Market Cap

-

P/E Ratio

-5

EPS

$20.43

52 Week High

$7.00

52 Week Low

HEALTHCARE

Sector

AMRN Chart

Recent Chart
Price Action

AMRN Technicals

Tags:

AMRN Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $81M
Total Revenue $229M
Cost Of Revenue $147M
Costof Goods And Services Sold $147M
Operating Income -$92M
Selling General And Administrative $73M
Research And Development $21M
Operating Expenses $173M
Investment Income Net -
Net Interest Income $13M
Interest Income $13M
Interest Expense $7K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $3M
Income Before Tax -$77M
Income Tax Expense $5M
Interest And Debt Expense -
Net Income From Continuing Operations -$82M
Comprehensive Income Net Of Tax -
Ebit -$77M
Ebitda -$74M
Net Income -$82M

Revenue & Profitability

Earnings Performance

AMRN Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $685M
Total Current Assets $595M
Cash And Cash Equivalents At Carrying Value $121M
Cash And Short Term Investments $121M
Inventory $166M
Current Net Receivables $122M
Total Non Current Assets $90M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $16M
Intangible Assets Excluding Goodwill $16M
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $173M
Other Current Assets $13M
Other Non Current Assets -
Total Liabilities $199M
Total Current Liabilities $180M
Current Accounts Payable $40M
Deferred Revenue -
Current Debt -
Short Term Debt -
Total Non Current Liabilities $19M
Capital Lease Obligations $7.7M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $7.7M
Other Current Liabilities $140M
Other Non Current Liabilities $12M
Total Shareholder Equity $486M
Treasury Stock -
Retained Earnings -$1.7B
Common Stock $305M
Common Stock Shares Outstanding $411M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$31M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $3M
Capital Expenditures $0
Change In Receivables -
Change In Inventory $105M
Profit Loss -
Cashflow From Investment -$46M
Cashflow From Financing -$1.4M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$82M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $81M
Total Revenue $229M
Cost Of Revenue $147M
Costof Goods And Services Sold $147M
Operating Income -$92M
Selling General And Administrative $73M
Research And Development $21M
Operating Expenses $173M
Investment Income Net -
Net Interest Income $13M
Interest Income $13M
Interest Expense $7K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $3M
Income Before Tax -$77M
Income Tax Expense $5M
Interest And Debt Expense -
Net Income From Continuing Operations -$82M
Comprehensive Income Net Of Tax -
Ebit -$77M
Ebitda -$74M
Net Income -$82M

AMRN News

AMRN Profile

Amarin Corporation PLC Profile

Sector: HEALTHCARE

Industry: DRUG MANUFACTURERS - GENERAL

Amarin Corporation PLC is a prominent pharmaceutical firm focused on developing and commercializing innovative therapies for cardiovascular disease, primarily in the United States. Based in Dublin, Ireland, Amarin is best known for its flagship product, Vascepa, which offers a unique and effective solution for reducing triglyceride levels in patients at risk of cardiovascular events. With a strong commitment to advancing cardiovascular health, the company continues to explore new clinical applications and market opportunities, positioning itself as a leader in the evolving healthcare landscape.

VHAI
+66.66%
$0.00
YYAI
-11.76%
$0.15
BURU
-20.39%
$0.40
UGRO
+54.52%
$0.57
NVDA
-4.40%
$180.03
CGBS
-39.47%
$0.03
PLUG
+6.26%
$4.14
BITF
+28.33%
$5.39
NVTS
+26.07%
$12.57
TMQ
+59.90%
$10.49
RGTI
+2.20%
$56.12
CAN
+18.42%
$1.80
DNN
+3.73%
$3.19
INTC
-4.27%
$35.63
LAES
+24.79%
$7.65
BYND
-23.22%
$0.79
JOBY
+8.05%
$18.12
RR
+4.34%
$6.73
RXRX
+6.50%
$5.89
SSKN
+41.55%
$2.18
ITP
+31.05%
$0.34
F
+1.08%
$11.66
EDHL
+114.42%
$1.07
CRML
+28.73%
$29.97
WULF
+10.42%
$15.46
ACHR
+1.91%
$13.01
BBD
+2.10%
$3.15
SOUN
+8.98%
$20.86
NAK
+4.13%
$2.76
TLRY
-5.32%
$1.60
QBTS
+5.93%
$43.03
DVLT
+24.76%
$2.12
IONZ
+11.73%
$2.57
BTBT
+3.25%
$4.13
GPUS
-6.93%
$0.40
TSLA
-1.52%
$429.24
MARA
+9.88%
$22.24
AMD
+0.77%
$218.09
SOFI
+2.68%
$27.87
AXDX
-61.36%
$0.03
CLF
+0.83%
$13.94
QS
+15.57%
$16.98
ERIC
+20.56%
$9.85
RIG
-2.65%
$3.11
ETHD
+6.45%
$3.54
CIFR
+2.70%
$20.89
NIO
-5.15%
$6.81
QUBT
+1.49%
$21.78
NUAI
+30.63%
$3.07
UAMY
+4.24%
$17.42
ASST
-7.69%
$0.99
NOK
+4.28%
$5.47
CLSK
+9.68%
$21.98
PLTR
+1.42%
$179.74
APLD
+2.33%
$35.04
IREN
+8.16%
$69.37
AREC
+36.74%
$6.81
ABAT
+36.59%
$9.22
RF
+2.44%
$25.16
BTG
+0.56%
$5.34
KDLY
-1.56%
$0.85
AAL
+1.90%
$11.74
USAR
-2.72%
$37.62
UUUU
+16.86%
$23.77
PFE
-0.82%
$24.52
BAC
+2.45%
$50.06
SNAP
-1.61%
$7.92
BMNR
-6.84%
$52.96
RMBL
+60.50%
$3.21
MP
+3.78%
$98.66
ADAP
-2.59%
$0.18
AMZN
-1.69%
$216.34
T
+2.11%
$26.13
ADD
-25.47%
$0.05
JBLU
+7.91%
$4.91
ONDS
-3.70%
$10.41
AAPL
+0.04%
$247.77
SRM
+53.27%
$10.30
ATXS
+37.07%
$11.61
HPE
+0.76%
$24.99
IONQ
-5.50%
$77.56
AQMS
+198.89%
$29.62
BCRX
-8.59%
$6.43
EOSE
-0.41%
$16.98
NAKA
-7.78%
$0.78
KDP
+2.32%
$26.42
GRAB
-0.33%
$5.91
RGTZ
-4.94%
$8.84
GWH
-15.91%
$7.61
BULL
-0.08%
$11.73
DFLI
-2.54%
$1.53
ABEV
+1.16%
$2.16
VALE
+2.41%
$11.01
NB
+3.09%
$11.67
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
WLGS
-5.57%
$0.04
GDXD
+3.16%
$0.75
FHN
+2.47%
$23.00
WWR
+29.29%
$2.56
VHAI
+66.66%
$0.00
YYAI
-11.76%
$0.15
BURU
-20.39%
$0.40
UGRO
+54.52%
$0.57
NVDA
-4.40%
$180.03
CGBS
-39.47%
$0.03
PLUG
+6.26%
$4.14
BITF
+28.33%
$5.39
NVTS
+26.07%
$12.57
TMQ
+59.90%
$10.49
RGTI
+2.20%
$56.12
CAN
+18.42%
$1.80
DNN
+3.73%
$3.19
INTC
-4.27%
$35.63
LAES
+24.79%
$7.65
BYND
-23.22%
$0.79
JOBY
+8.05%
$18.12
RR
+4.34%
$6.73
RXRX
+6.50%
$5.89
SSKN
+41.55%
$2.18
ITP
+31.05%
$0.34
F
+1.08%
$11.66
EDHL
+114.42%
$1.07
CRML
+28.73%
$29.97
WULF
+10.42%
$15.46
ACHR
+1.91%
$13.01
BBD
+2.10%
$3.15
SOUN
+8.98%
$20.86
NAK
+4.13%
$2.76
TLRY
-5.32%
$1.60
QBTS
+5.93%
$43.03
DVLT
+24.76%
$2.12
IONZ
+11.73%
$2.57
BTBT
+3.25%
$4.13
GPUS
-6.93%
$0.40
TSLA
-1.52%
$429.24
MARA
+9.88%
$22.24
AMD
+0.77%
$218.09
SOFI
+2.68%
$27.87
AXDX
-61.36%
$0.03
CLF
+0.83%
$13.94
QS
+15.57%
$16.98
ERIC
+20.56%
$9.85
RIG
-2.65%
$3.11
ETHD
+6.45%
$3.54
CIFR
+2.70%
$20.89
NIO
-5.15%
$6.81
QUBT
+1.49%
$21.78
NUAI
+30.63%
$3.07
UAMY
+4.24%
$17.42
ASST
-7.69%
$0.99
NOK
+4.28%
$5.47
CLSK
+9.68%
$21.98
PLTR
+1.42%
$179.74
APLD
+2.33%
$35.04
IREN
+8.16%
$69.37
AREC
+36.74%
$6.81
ABAT
+36.59%
$9.22
RF
+2.44%
$25.16
BTG
+0.56%
$5.34
KDLY
-1.56%
$0.85
AAL
+1.90%
$11.74
USAR
-2.72%
$37.62
UUUU
+16.86%
$23.77
PFE
-0.82%
$24.52
BAC
+2.45%
$50.06
SNAP
-1.61%
$7.92
BMNR
-6.84%
$52.96
RMBL
+60.50%
$3.21
MP
+3.78%
$98.66
ADAP
-2.59%
$0.18
AMZN
-1.69%
$216.34
T
+2.11%
$26.13
ADD
-25.47%
$0.05
JBLU
+7.91%
$4.91
ONDS
-3.70%
$10.41
AAPL
+0.04%
$247.77
SRM
+53.27%
$10.30
ATXS
+37.07%
$11.61
HPE
+0.76%
$24.99
IONQ
-5.50%
$77.56
AQMS
+198.89%
$29.62
BCRX
-8.59%
$6.43
EOSE
-0.41%
$16.98
NAKA
-7.78%
$0.78
KDP
+2.32%
$26.42
GRAB
-0.33%
$5.91
RGTZ
-4.94%
$8.84
GWH
-15.91%
$7.61
BULL
-0.08%
$11.73
DFLI
-2.54%
$1.53
ABEV
+1.16%
$2.16
VALE
+2.41%
$11.01
NB
+3.09%
$11.67
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
WLGS
-5.57%
$0.04
GDXD
+3.16%
$0.75
FHN
+2.47%
$23.00
WWR
+29.29%
$2.56
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.